Skip to main content

Table 1 Demographic and clinical data of symptomatic carotid stenosis patients

From: Upregulation of miR-330-5p is associated with carotid plaque’s stability by targeting Talin-1 in symptomatic carotid stenosis patients

 

Stable Plaque

(n = 10)

Unstable Plaque

(n = 10)

Age, years

64.10 ± 5.20

65.70 ± 6.70

Sex, male:female

6:4

6:4

Hypertension, n (%)

7 (70.00)

5 (50.00)

Hyperlipidemia, n (%)

3 (30.00)

4 (40.00)

Diabetes mellitus, n (%)

1 (10.00)

0 (0.00)

Coronary artery disease, n (%)

0 (0.00)

0 (0.00)

Previous MI, n (%)

0 (0.00)

0 (0.00)

Previous Stroke, n (%)

2 (20.00)

2 (20.00)

Body mass index, kg/m2

24.52 ± 3.16

23.51 ± 2.40

Carotid Stenosis, (%)

84.60 ± 7.06

82.70 ± 7.09

Current smoking, n (%)

4 (40.00)

3 (30.00)

Alcohol consumption, n (%)

2 (20.00)

1 (10.00)

Previous or ongoing drug treatment, n (%)

 Antihypertensive drugs

3 (30.00)

5 (50.00)

 Hypoglycemic drugs

1 (10.00)

0 (0.00)

 Statins

0 (0.00)

0 (0.00)

 Antiplatelet drugs

0 (0.00)

0 (0.00)

TG, mmol/L

1.18 ± 0.41

1.47 ± 0.60

HDL, mmol/L

1.10 ± 0.12

1.12 ± 0.13

LDL, mmol/L

1.70 ± 0.28

1.84 ± 0.35

Creatinine, mg/dL

71.10 ± 18.52

65.40 ± 17.40

eGFR, ml/min/1.73m2

75.47 ± 42.68

82.93 ± 26.01